Saturday, August 01, 2026

GET OUR FREE E-NEWSLETTER

“You may choose to look the other way, but you can never say again that you did not know.”

— William Wilberforce

Search

Meningococcal B Vaccine Fails to Protect Against Gonorrhea

Meningococcal B Vaccine Fails to Protect Against Gonorrhea

A new randomized controlled trial (RCT) published in the New England Journal of Medicine (NEJM) has found that the Meningitis B vaccine does not prevent gonorrhea infections despite a year-long mass vaccination campaign targeting at-risk men in the United Kingdom. After gonorrhea cases exceeded the highest levels ever recorded, the U.K.’s National Health Service (NHS) […]

Oral Vaccine Being Developed for Invasive Bacterial Diarrhea

Oral Vaccine Being Developed for Invasive Bacterial Diarrhea

Researchers are taking steps toward developing an live attenuated oral vaccine aimed at preventing invasive bacterial diarrhea caused by the Shigella bacteria.1 The Shigella bacteria can cause shigellosis—an intestinal infection characterized by diarrhea, fever and stomach cramps. It is one of four highly contagious bacteria that infects tens of millions of people around the world.2 […]

CDC Just Awarded Pfizer $1.2 Billion for COVID-19 Shots

CDC Just Awarded Pfizer .2 Billion for COVID-19 Shots

U.S. federal procurement records published in June 2026 show that the U.S. Centers for Disease Control and Prevention (CDC) awarded Pfizer more than $1.24 billion in contracts for adult and pediatric mRNA COVID-19 shots for fiscal years 2026 and 2027. The contracts, which were published on SAM.gov and contained more money allocated for pediatric COVID […]

Experimental Vaccine to Prevent Fentanyl Overdose Enters Human Trials

Experimental Vaccine to Prevent Fentanyl Overdose Enters Human Trials

An experimental “anti-fentanyl” vaccine developed by ARMR Sciences, Inc. of New York and the University of Houston has entered Phase 1/2 human trials, according to a June 17 press release issued by the company. The vaccine candidate has spent years in development and vaccine developers say it represents a potential intervention in America’s ongoing overdose […]

Mussel Protein Used to Develop New Vaccine Technology

Mussel Protein Used to Develop New Vaccine Technology

Scientists in South Korea have developed a new adhesive adjuvant protein-based nanoparticle vaccine technology that they believe may provide longer-lasting immunity with a single injection. According to the researchers in a study published in the journal Biomaterials in 2026, the new approach used bioengineering, gene synthesis and cloning to create a new vaccine technology using […]

Search in Site

To search in site, type your keyword and hit enter

Search
The Vaccine Reaction
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.